These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1973889)

  • 1. Glutamate dysfunction and selective motor neuron degeneration in amyotrophic lateral sclerosis: a hypothesis.
    Plaitakis A
    Ann Neurol; 1990 Jul; 28(1):3-8. PubMed ID: 1973889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on the glutamatergic neurotransmitter system and the role of excitotoxicity in amyotrophic lateral sclerosis.
    Heath PR; Shaw PJ
    Muscle Nerve; 2002 Oct; 26(4):438-58. PubMed ID: 12362409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered glutamatergic mechanisms and selective motor neuron degeneration in amyotrophic lateral sclerosis: possible role of glycine.
    Plaitakis A
    Adv Neurol; 1991; 56():319-26. PubMed ID: 1677233
    [No Abstract]   [Full Text] [Related]  

  • 4. Amyotrophic lateral sclerosis: alterations in neurotransmitter receptors.
    Whitehouse PJ; Wamsley JK; Zarbin MA; Price DL; Tourtellotte WW; Kuhar MJ
    Ann Neurol; 1983 Jul; 14(1):8-16. PubMed ID: 6137185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant control of motoneuronal excitability in amyotrophic lateral sclerosis: excitatory glutamate/D-serine vs. inhibitory glycine/gamma-aminobutanoic acid (GABA).
    Sasabe J; Aiso S
    Chem Biodivers; 2010 Jun; 7(6):1479-90. PubMed ID: 20564566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis.
    Plaitakis A; Constantakakis E; Smith J
    Ann Neurol; 1988 Sep; 24(3):446-9. PubMed ID: 2906529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyotrophic lateral sclerosis: amino acid levels in plasma and cerebrospinal fluid.
    Perry TL; Krieger C; Hansen S; Eisen A
    Ann Neurol; 1990 Jul; 28(1):12-7. PubMed ID: 2375629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis.
    Siklós L; Engelhardt J; Harati Y; Smith RG; Joó F; Appel SH
    Ann Neurol; 1996 Feb; 39(2):203-16. PubMed ID: 8967752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitotoxicity and neurodegeneration in amyotrophic lateral sclerosis.
    Rothstein JD
    Clin Neurosci; 1995-1996; 3(6):348-59. PubMed ID: 9021256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal glutamate metabolism in amyotrophic lateral sclerosis.
    Plaitakis A; Caroscio JT
    Ann Neurol; 1987 Nov; 22(5):575-9. PubMed ID: 2892463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microglia in amyotrophic lateral sclerosis.
    Dewil M; Van Den Bosch L; Robberecht W
    Acta Neurol Belg; 2007 Sep; 107(3):63-70. PubMed ID: 18072333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonergic mechanisms in amyotrophic lateral sclerosis.
    Sandyk R
    Int J Neurosci; 2006 Jul; 116(7):775-826. PubMed ID: 16861147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excitotoxic mechanisms in the pathogenesis of amyotrophic lateral sclerosis.
    Rothstein JD
    Adv Neurol; 1995; 68():7-20; discussion 21-7. PubMed ID: 8787245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Excitotoxins and amyotrophic lateral sclerosis.
    Munsat TL; Hollander D
    Therapie; 1990; 45(3):277-9. PubMed ID: 2194313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early signs of motoneuron vulnerability in a disease model system: Characterization of transverse slice cultures of spinal cord isolated from embryonic ALS mice.
    Avossa D; Grandolfo M; Mazzarol F; Zatta M; Ballerini L
    Neuroscience; 2006; 138(4):1179-94. PubMed ID: 16442737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence against the presence of NMDA receptors at a central glutamatergic synapse in leeches.
    Wu E
    Invert Neurosci; 2002 Apr; 4(3):157-64. PubMed ID: 12488975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebrospinal fluid from amyotrophic lateral sclerosis patients preferentially elevates intracellular calcium and toxicity in motor neurons via AMPA/kainate receptor.
    Sen I; Nalini A; Joshi NB; Joshi PG
    J Neurol Sci; 2005 Aug; 235(1-2):45-54. PubMed ID: 15936037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cocaine use and abuse triggering sporadic young-onset amyotrophic lateral sclerosis.
    Argyriou AA; Karanasios P; Makridou A; Vlachou M; Giannakopoulou F; Makris N
    Neurodegener Dis; 2011; 8(3):146-8. PubMed ID: 20714119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excitatory amino acid receptors and neurodegeneration.
    Doble A
    Therapie; 1995; 50(4):319-37. PubMed ID: 7482387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amino acid metabolism in the central nervous system: role of glutamate dehydrogenase.
    Nicklas WJ
    Adv Neurol; 1984; 41():245-53. PubMed ID: 6149678
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.